NERV vs SLS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

NERV

38.3
AI Score
VS
SLS Wins

SLS

48.8
AI Score

Investment Advisor Scores

NERV

38score
Recommendation
SELL

SLS

49score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NERV SLS Winner
Net Income -8.80M -29.20M NERV
Operating Income -7.51M -29.69M NERV
ROE -19.4% 763.1% SLS
ROA -7.9% -361.2% NERV
Total Assets 111.83M 8.09M NERV
Cash 80.14M 3.97M NERV
Current Ratio 24.32 0.44 NERV

Relative Price Performance (Last 90 Days)

NERV 1M: +5.9% · 3M: -10.2% SLS 1M: -1.9% · 3M: +49.0%

Current Technical Phase

NERV

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.2%), weak momentum, RSI 42

RSI (14): 42.0 · Price: $4.15

SLS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 40.6 · Price: $11.55

Fundamentals Snapshot

Metric NERV SLS
Market Cap
Forward P/E -9.9 -115.5
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% -0.8%
Gross Margin
Operating Margin 0.0% 0.0%
EPS -36.29 -0.22
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, SLS is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.